Why Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today

MotleyFool01-02

The S&P/ASX 200 Index (ASX: XJO) is on course to start the year with a decent gain. At the time of writing, the benchmark index is up 0.4% to 8,192.9 points. Four ASX shares that are rising more than ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2500697309?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-02 09:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2500697309","market":"us","top_or_hot":-1,"title":"Why Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today","media":"MotleyFool","content":"<div>\n<p>The S&P/ASX 200 Index (ASX: XJO) is on course to start the year with a decent gain. At the time of writing, the benchmark index is up 0.4% to 8,192.9 points. Four ASX shares that are rising more than ...</p>\n\n<a href=\"https://www.fool.com.au/2025/01/02/why-brainchip-fortescue-mesoblast-and-qbe-shares-are-racing-higher-today/\">Source Link</a>\n\n</div>\n","source":"motleyfoolau_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-02 09:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com.au/2025/01/02/why-brainchip-fortescue-mesoblast-and-qbe-shares-are-racing-higher-today/><strong>MotleyFool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P/ASX 200 Index (ASX: XJO) is on course to start the year with a decent gain. At the time of writing, the benchmark index is up 0.4% to 8,192.9 points. Four ASX shares that are rising more than ...</p>\n\n<a href=\"https://www.fool.com.au/2025/01/02/why-brainchip-fortescue-mesoblast-and-qbe-shares-are-racing-higher-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://www.fool.com.au/2025/01/02/why-brainchip-fortescue-mesoblast-and-qbe-shares-are-racing-higher-today/","article_id":"2500697309","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500697309","pubTimestamp":1735782891,"columns":[],"sourceInfo":{"source_id":"motleyfoolau_stock","name":"MotleyFool"},"weMediaInfo":null,"summary":"TheS&P/ASX 200 Index (ASX: XJO) is on course to start the year with a decent gain. At the time of writing, the benchmark index is up 0.4% to 8,192.9 points. Four ASX shares that are rising more than m","collect":0,"end_time":0,"defaultTopTitle":"fool.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","BK7034":"财产与意外伤害保险","MSB.AU":"MESOBLAST LTD","BK4139":"生物科技","MSC":"新濠影汇","BK7016":"应用软件","BK7067":"生物科技","FMG.AU":"FORTESCUE LTD","BK4575":"芯片概念","QBE.AU":"QBE INSURANCE GROUP LTD","MESO":"Mesoblast Limited","BRN.AU":"BRAINCHIP HOLDINGS LTD","BK4150":"赌场与赌博","BK7501":"新冠治疗股","BK7507":"资源股","XJO.AU":"标普/澳交所 200指数","BK7129":"钢铁"},"translate_title":"为什么Brainchip、Fortescue、Mesoblast和QBE股价今天上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XJO.AU":1,"QBE.AU":1,"MSC":1,"MSB.AU":1,"MESO":1,"FMG.AU":1,"BRN.AU":1},"content_text":"The S&P/ASX 200 Index (ASX: XJO) is on course to start the year with a decent gain. At the time of writing, the benchmark index is up 0.4% to 8,192.9 points. Four ASX shares that are rising more than most today are listed below. Here's why they are climbing: Brainchip Holdings Ltd (ASX: BRN) The Brainchip share price is up a further 10% to 43 cents. This semiconductor company's shares have been on fire over the holiday period despite there being no news out of it. The gains have been so strong that the Australian stock exchange operator issued a speeding ticket to find out what was going on. Brainchip was unable to explain the share price gains. It will be interesting to see if these share price gains can be maintained once the holiday period ends, institutional investors return, and Brainchip releases its next quarterly update. Fortescue Ltd (ASX: FMG) The Fortescue share price is up 2.5% to $18.72. Investors have been buying miners on Thursday possibly on the belief that they were oversold in 2024. As a result, both the energy and materials sectors are roaring higher today and acting as the main drivers of the ASX 200 index's gain. Fortescue shares remain down 36% since this time last year. Mesoblast Ltd (ASX: MSB) The Mesoblast share price is up 5% to $3.27. Investors have been fighting to get hold of this biotechnology company's shares during the last couple of weeks thanks to the approval of one of its stem cell therapies. The US FDA approved its Ryoncil (remestemcel-L) product as the first mesenchymal stromal cell (MSC) therapy in the United States. Ryoncil is also the only MSC therapy approved in the U.S. for any indication and the only approved therapy for steroid-refractory acute graft versus host disease (SR-aGvHD) in children two months and older. QBE Insurance Group Ltd (ASX: QBE) The QBE Insurance share price is up over 1% to $19.41. This morning, Goldman Sachs reaffirmed its buy rating and $20.00 price target on the insurance giant's shares. It noted that Guy Carpenter (GC) and AON released their initial view of 1 January 2025 reinsurance renewals and sees the \"updates as incrementally positive\" for QBE. It adds that \"insurers were also able to purchase protection at lower levels driven by increased reinsurer appetite.\" This appears to bode well for QBE and other insurers in 2025.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2500697309"}